EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Natural products for combatting antibiotic-resistant Gram-negative bacteria: Role, mechanism, and future direction

Fayin Mo, Jingwen Jiang, Wenyong Yang, Ling Ding, Long Ge, Wen Wang, Xin Sun

Journal of Pharmaceutical Analysis · 2026-06 · 101704

DOI: 10.1016/j.jpha.2026.101704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-06. Verfasst von Fayin Mo und 6 weiteren Autor:innen. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gram-negative bacteria (GNB) infection therapy poses a significant challenge in the field of infectious diseases due to their extensive resistance to clinically advanced antibiotics such as carbapenems and third-generation cephalosporins, and novel therapeutic options are urgently needed. Unlike single-target antibiotics, natural products derived from herbs exert therapeutic effects through synergistic mechanisms, including bacterial growth inhibition, modulation of inflammatory pathways, and regulation of microbial balance and host immune function. In this review, we systematically summarized natural products that have demonstrated promising efficacy against drug-resistant GNB. We highlighted several widely used natural product formulations with validated therapeutic outcomes through rigorous clinical trials, including Tanreqing injection (TRQ) and Xuebijing injection (XBJ). The active constituents of these natural products and their mechanisms of action are thoroughly discussed, providing valuable insights into the potential of natural products for developing combinational anti-drug-resistant GNB agents. Moreover, an overview of opportunities and challenges in achieving standardized quality control, multi-target/antibiotic synergy, exploration of molecular mechanisms of action, and clinical practice transformation. Finally, this review summarizes the key challenges in the clinical translation of natural products and emphasizes the importance of advancing multi-target/antibiotic synergistic therapies, establishing standardized quality control protocols, and elucidating molecular mechanisms of action.

Förderung

  • National Natural Science Foundation of China
  • National Science Fund for Distinguished Young Scholars

Zitieren

APA

Mo, F., Jiang, J., Yang, W., Ding, L., Ge, L., Wang, W., & Sun, X. (2026). Natural products for combatting antibiotic-resistant Gram-negative bacteria: Role, mechanism, and future direction. Journal of Pharmaceutical Analysis, 101704. https://doi.org/10.1016/j.jpha.2026.101704

Vancouver

Mo F, Jiang J, Yang W, Ding L, Ge L, Wang W, et al. Natural products for combatting antibiotic-resistant Gram-negative bacteria: Role, mechanism, and future direction. Journal of Pharmaceutical Analysis. 2026:101704. doi:10.1016/j.jpha.2026.101704

BibTeX
@article{Mo2026,
  author = {Mo, Fayin and Jiang, Jingwen and Yang, Wenyong and Ding, Ling and Ge, Long and Wang, Wen and Sun, Xin},
  title = {Natural products for combatting antibiotic-resistant Gram-negative bacteria: Role, mechanism, and future direction},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  pages = {101704},
  doi = {10.1016/j.jpha.2026.101704}
}
Kostenlos starten →